New #JITC article: Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma https://bit.ly/4eEojxS Clinical Cancer Institute of Nanjing University, Nanjing, China
Journal for ImmunoTherapy of Cancer’s Post
More Relevant Posts
-
New #JITC article: Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells https://bit.ly/3VLm7fu Winship Cancer Institute of Emory University
-
-
New #JITC article: Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis https://bit.ly/3VKrU56
-
-
New #JITC article: Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy https://bit.ly/3KXcRzV. Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China
-
-
New #JITC position article and guidelines - Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision https://bit.ly/4evIXAp #CIM24 Authors: Leisha Emens, Pedro Romero, Ana Anderson, Tullia Bruno, Christian M Capitini, Deborah Collyar, James Gulley, Patrick Hwu, Avery Posey, Jr., Ann W. Silk, Jennifer A Wargo
-
